Cordis Announces The Completion Of Its Acquisition Of Medalliance
Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, announced that it has completed the acquisition of MedAlliance,...
FreedomFlow® Orbital Atherectomy Peripheral Platform Receives Regulatory Approval from Cardio Flow,...
Cardio Flow, a private medical device firm focusing in minimally invasive peripheral artery disease (PAD) treatments, has received FDA 510(k) clearance for its FreedomFlow...